CVC-Led Shareholders Plug €210 Million Cash Into Lipton Teas

A group of shareholders led by CVC Capital Partners has injected €210 million ($245 million) into Lipton Teas and Infusions to support a turnaround of the business.

The funding — a mix of fresh equity and new loans from shareholders — follows €40 million provided last year, according to a person familiar with the matter, who asked not to be identified discussing private matters. About €160 million of the new funds are formed of secured debt issued against Lipton Tea’s intellectual property outside of the US, the person added.